1
Repository Corticotropin Injection in Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:December 14, 2018Withdrawn
Keratoconjunctivitis Sicca: 1221 Clinical Trials, Page 1 of 123
Hide Studies Not Open or Pending
2
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:August 29, 2022Completed
3
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
Condition(s):Keratoconjunctivitis SiccaLast Updated:August 30, 2019Completed
4
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:May 9, 2022Completed
5
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:November 19, 2021Completed
6
Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:May 27, 2020Completed
7
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Condition(s):Keratoconjunctivitis SiccaLast Updated:October 3, 2016Completed
8
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
Condition(s):Keratoconjunctivitis SiccaLast Updated:February 20, 2012Completed
9
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
Condition(s):Keratoconjunctivitis SiccaLast Updated:August 16, 2019Completed
10
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
Condition(s):Keratoconjunctivitis SiccaLast Updated:June 11, 2014Completed